Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs

Veterinary Therapeutics

Volumn 9, Issue 2, 2008, Pages 83-93

  Abbo, Lisa A ^a   Ko, Jeff C H ^a   Maxwell, Lara K ^b   Galinsky, Raymond E ^c   Moody, David E ^d   Johnson, Brenda M ^a   Fang, Wenfang B ^d  

^a PURDUE UNIVERSITY   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; NARCOTIC ANALGESIC AGENT;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOG; DOG DISEASE; DOSE RESPONSE; DRUG EFFECT; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE ABSORPTION; INTRAVENOUS DRUG ADMINISTRATION; MASS SPECTROMETRY; METABOLISM; ORAL DRUG ADMINISTRATION; PAIN; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BUPRENORPHINE; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; MASS SPECTROMETRY; PAIN; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 48049101709     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Garrett ER, Chandran VR. Pharmacokinetics of morphine and its surrogates x: analyses and pharmacokinetics of buprenorphine in dogs. Biopharm Drug Dispos 1990;11:311-350.
2. McInnes F, Clear N, James G, et al. Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy. Pharm Res 2008; 25:869-874.
3. Bullingham RES, McQuay HJ, Porter EJB, et al. Sublingual buprenorphine used postoperatively: ten hour plasma drug concentrations analysis. Br J Clin Pharmacol 1982;13:665-673.
4. Kuhlman JJ Jr, Lalani S, Magluilo J Jr, et al. Human pharmacokinetics of intravenous sublingual and buccal buprenorphine. J Anal Toxicol 1996;20:369-378.
5. Weinberg DS, Inturrisi CE, Reidenberg B, et al. Sublingual absorption of selected opioid analgesics. Clin Pharmacol Ther 1988;44:335-342.
6. Nath RP, Upton RA, Everhart ET, et al. Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations. J Clin Pharmacol 1999;39:619-623.
7. Robertson SA, Lascelles BDX, Taylor PM, Sear JW. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration. J Vet Pharmacol Ther 2005:28:453-460.
8. Taylor PM, Houlton JEF. Post-operative analgesia in the dog: a comparison of morphine buprenorphine and pentazocine. J Small Anim Pract 1984;25:437-451.
9. Slingsby LS, Taylor PM, Waterman-Pearson AE. Effects of two doses of huprenorphine four or six hours apart on nociceptive thresholds, pain and sedation in dogs after castration. Vet Rec 2006;159:705-711.
10. Shih AC, Robertson S, Isaza N, et al. Comparison between analgesic effects of buprenorphine, carprofen, and buprenorphine with carprofen for canine ovariohysterectomy. Vet Anaesth Analg 2008;35:69-79.
11. Huang W, Moody DE, McCance-Katz EE The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry. Ther Drug Monit 2006;28:245-251.
12. Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-175.
13. Dohoo SE, Tasker RAR. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations. Can J Vet Res 1997;61:251-255.
14. KuKanich B, Lascelles BDX, Papich MG. Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs. J Vet Pharmacol Ther 2005;28:371-376.
15. Mendelson J, Upton RA, Everhart ET, et al. Bioavailability of sublingual buprenorphine. J Clin Pharmacol 1997;37:31-37.
16. Robertson SA, Taylor PM, Sear JW. Systemic uptake of buprenorphine by cats after oral mucosal administration. Vet Rec 2003;152:675-678.
17. Walker AE Sublingual administration of buprenorphine for long-term analgesia in the horse. Vet Rec 2007;160:808-809.
18. Ko JCH, Maxwell LK, Moody DE, Abbo LA: Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in cats. Unpublished data, Purdue University.
19. Chang Y, Moody DE, McCance-Katz EE Novel metabolites of buprenorphine detected in human liver microsomes and human urine. Drug Metab Dispos 2006;34:440-448.
20. Picard N, Cresteiol T, Djedli N, Marquet P. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways. Drug Metab Dispos 2005;33:689-695.
21. Huang P, Kehner GB, Cowan A, Liu-Chen LY: Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. J Pharmacol Exp Ther 2001; 297:688-695.